Pacific Biosciences Of California reported $30.61M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Accelerate Diagnostics AXDX:US 2.8M 280K
Agilent A:US $ 1586M 61M
Bruker BRKR:US $ 570.8M 16.1M
Danaher DHR:US $ 7218M 360M
Fluidigm FLDM:US $ 31.02M 1.78M
General Electric GE:US $ 18280M 1161M
Genmark Diagnostics GNMK:US $ 50.08M 7.43M
Illumina ILMN:US $ 1126M 33M
Luminex LMNX:US $ 110.69M 0.7M
Myriad Genetics MYGN:US $ 189.4M 16.3M
Nanostring Technologies NSTG:US $ 33.86M 2.25M
Oxford Immunotec Global OXFD:US $ 19.44M 13.6M
Pacific Biosciences Of California PACB:US $ 30.61M 1.61M
Perkinelmer PKI:US $ 1228.47M 79.22M
Quidel QDEL:US $ 176.61M 198.73M
Thermo Fisher Scientific TMO:US $ 9273M 633M
Waters WAT:US $ 681.65M 73.1M